Coronavirus updates: Colleges could reopen if they test students every 2 days; Fauci 'cautiously optimistic' for vaccine this year (usatoday.com)

Coronavirus updates: Colleges could reopen if they test students every 2 days; Fauci 'cautiously optimistic' for vaccine this year

The deal is part of Operation Warp Speed, a White House-led initiative aimed at getting a vaccine to stop SARS-CoV-2, the virus that causes COVID-19.

Submitted by mo2 on Fri, 07/31/2020 - 20:34

Operation Warp Speed leader says he expects coronavirus vaccine to be highly effective, 'in the 90%' range (cnn.com)

Operation Warp Speed leader says he expects coronavirus vaccine to be highly effective, 'in the 90%' range

(CNN) The head of the government's effort to develop a vaccine against Covid-19 says he expects the vaccine to have efficacy rates "in the 90%" range -- but that there might not be enough vaccine available for all Americans until the end of next year.

Submitted by mo2 on Fri, 07/31/2020 - 19:50
CDC documents say states should prepare to distribute Covid-19 vaccines as soon as late October

The US Centers for Disease Control and Prevention has told public health officials around the United States to prepare to distribute a potential coronavirus vaccine as soon as late October. It also provided planning scenarios to help states prepare.

Submitted by mo2 on Mon, 07/27/2020 - 21:28
Dr. Anthony Fauci isn't 'particularly concerned' about the safety of Moderna coronavirus vaccine
  • White House coronavirus advisor Dr. Anthony Fauci said Monday he is "not particularly concerned" about the safety risk of a potential coronavirus vaccine by Moderna, despite the fact that it uses new technology to fight the virus. 
  • The vaccine, which entered a large phase-three human trial Monday, uses messenger ribonucleic acid, or mRNA molecules, to provoke an immune response to fight the virus.
Submitted by mo2 on Mon, 07/27/2020 - 20:58

First Phase 3 clinical trial of a coronavirus vaccine in the United States begins (cnn.com)

First Phase 3 clinical trial of a coronavirus vaccine in the United States begins

Savannah, Georgia The first Phase 3 clinical trial of a coronavirus vaccine in the United States began Monday.

The investigational vaccine was developed by the biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial is to be conducted at nearly 100 US research sites, according to Moderna. The first patient was dosed at a site in Savannah, Georgia.

Submitted by Admin on Mon, 07/27/2020 - 19:49